These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 57451)

  • 1. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sorensen E; Brochner-Mortensen J; Christensen MS; Rodbro P; Sorensen AW
    Lancet; 1976 May; 1(7968):1044-7. PubMed ID: 57451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sörensen E; Bröchner-Mortensen J; Christensen MS; Rödbro P; Sörensen AW
    Calcif Tissue Res; 1977 May; 22 Suppl():101-4. PubMed ID: 334342
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
    Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
    Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-alpha-hydroxycholecalciferol treatment of adults with chronic renal failure.
    Madsen S; Olgaard K
    Acta Med Scand; 1976; 200(1-2):1-5. PubMed ID: 961464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of 25-hydroxycholecalciferol on calcium metabolism in chronic renal failure.
    Letteri JM; Kleinman LM; Ellis KN; Caselnova R; Akhtar M; Cohn SH
    Adv Exp Med Biol; 1977; 81():591-601. PubMed ID: 899943
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
    Henderson RG; Russell RG; Ledingham JG; Smith R; Oliver DO; Walton RJ; Small DG; Preston C; Warner GT
    Lancet; 1974 Mar; 1(7854):379-84. PubMed ID: 4131033
    [No Abstract]   [Full Text] [Related]  

  • 9. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
    Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
    Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
    Eke FU; Winterborn MH
    Arch Dis Child; 1983 Oct; 58(10):810-3. PubMed ID: 6357106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.
    Hirooka M; Wako H; Kaneko C; Ishikawa M; Sasaki S
    J Nutr Sci Vitaminol (Tokyo); 1975; 21(4):277-85. PubMed ID: 1214180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 1alpha-hydroxyvitamin D3 on calcium and mineral content of bone in renal osteodystrophy.
    Junor BJ; Catto GR
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():131s-138s. PubMed ID: 606411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
    Kanis JA; Henderson RG; Heynen G; Ledingham JG; Russell RG; Smith R; Walton RJ
    Arch Dis Child; 1977 Jun; 52(6):473-81. PubMed ID: 879833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcifediol in chronic renal insufficiency. Skeletal response.
    Teitelbaum SL; Bone JM; Stein PM; Gilden JJ; Bates M; Boisseau VC; Avioli LV
    JAMA; 1976 Jan; 235(2):164-7. PubMed ID: 946022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.
    Rix M; Eskildsen P; Olgaard K
    Nephrol Dial Transplant; 2004 Apr; 19(4):870-6. PubMed ID: 15031343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ionized calcium in renal failure --- a guideline for 1alpha-hydroxycholecalciferol treatment.
    Nielsen SP; Christiansen TF; Christensen MS; Clausen E; Krolner B; Lund B; Melsen F; Schaadt O; Sorensen OH
    Calcif Tissue Res; 1977 May; 22 Suppl():85-93. PubMed ID: 21026
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone composition and parathyroid function in chronic renal failure.
    Tougaard L; Sorensen E; Christensen MS; Brochner-Mortensen J; Rodbro P; Sorensen AW
    Acta Med Scand; 1977; 202(1-2):33-8. PubMed ID: 899880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-year controlled trial of 1 alpha-hydroxycholecalciferol in patients on maintenance hemodialysis.
    Shimamatsu K; Maeda T; Harada A; Nishitani H; Onoyama K; Fujimi S; Omae T
    Nephron; 1981; 28(2):70-5. PubMed ID: 7027062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.